Abbott to buy St. Jude for $25 bln to boost heart devices

Abbott Laboratories (ABT.N) said it would buy St. Jude Medical Inc (STJ.N) for $25 billion to expand its heart device business as it competes with larger rivals Medtronic Plc (MDT.N) and Boston Scientific Corp (BSX.N).

DealsNorth AmericaUSBriefs